{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:17:43Z","timestamp":1787887063280,"version":"build-2784847793"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82222067"],"award-info":[{"award-number":["82222067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172762"],"award-info":[{"award-number":["82172762"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U23A20531"],"award-info":[{"award-number":["U23A20531"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M763014"],"award-info":[{"award-number":["2024M763014"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08400-x","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T20:44:17Z","timestamp":1781729057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CD45 as a multifunctional target in immune regulation and therapeutic delivery"],"prefix":"10.1186","volume":"24","author":[{"given":"Kaikai","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1531-7265","authenticated-orcid":false,"given":"Jinjin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"8400_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1006\/scel.1993.1049","volume":"4","author":"T Woodford-Thomas","year":"1993","unstructured":"Woodford-Thomas T, Thomas ML. The leukocyte common antigen, CD45 and other protein tyrosine phosphatases in hematopoietic cells. Semin Cell Biol. 1993;4:409\u201318. https:\/\/doi.org\/10.1006\/scel.1993.1049.","journal-title":"Semin Cell Biol"},{"key":"8400_CR2","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1681\/ASN.V44976","volume":"4","author":"JA Donovan","year":"1993","unstructured":"Donovan JA, Koretzky GA. CD45 and the immune response. J Am Soc Nephrol. 1993;4:976. https:\/\/doi.org\/10.1681\/ASN.V44976.","journal-title":"J Am Soc Nephrol"},{"key":"8400_CR3","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1073\/pnas.85.19.7182","volume":"85","author":"H Charbonneau","year":"1988","unstructured":"Charbonneau H, Tonks NK, Walsh KA, Fischer EH. The leukocyte common antigen (CD45): a putative receptor-linked protein tyrosine phosphatase. Proc Natl Acad Sci. 1988;85:7182\u20136. https:\/\/doi.org\/10.1073\/pnas.85.19.7182.","journal-title":"Proc Natl Acad Sci"},{"key":"8400_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev.immunol.21.120601.140946","volume":"21","author":"ML Hermiston","year":"2003","unstructured":"Hermiston ML, Xu Z, Weiss A. CD45: A Critical Regulator of Signaling Thresholds in Immune Cells. Annu Rev Immunol. 2003;21:107\u201337. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.140946.","journal-title":"Annu Rev Immunol"},{"key":"8400_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/protein\/12.10.885","volume":"12","author":"A Symons","year":"1999","unstructured":"Symons A, Willis AC, Barclay AN. Domain organization of the extracellular region of CD45. Protein Eng Des Sel. 1999;12:885\u201392. https:\/\/doi.org\/10.1093\/protein\/12.10.885.","journal-title":"Protein Eng Des Sel"},{"key":"8400_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0960-9822(00)00362-6","volume":"10","author":"O Leupin","year":"2000","unstructured":"Leupin O, Zaru R, Laroche T, M\u00fcller S, Valitutti S. Exclusion of CD45 from the T-cell receptor signaling area in antigen-stimulated T lymphocytes. Curr Biol. 2000;10:277\u201380. https:\/\/doi.org\/10.1016\/S0960-9822(00)00362-6.","journal-title":"Curr Biol"},{"key":"8400_CR7","doi-asserted-by":"publisher","first-page":"10138","DOI":"10.1073\/pnas.97.18.10138","volume":"97","author":"KG Johnson","year":"2000","unstructured":"Johnson KG, Bromley SK, Dustin ML, Thomas ML. A supramolecular basis for CD45 tyrosine phosphatase regulation in sustained T cell activation. Proc Natl Acad Sci. 2000;97:10138\u201343. https:\/\/doi.org\/10.1073\/pnas.97.18.10138.","journal-title":"Proc Natl Acad Sci"},{"key":"8400_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/ni836","volume":"3","author":"BA Freiberg","year":"2002","unstructured":"Freiberg BA, Kupfer H, Maslanik W, Delli J, Kappler J, Zaller DM, et al. Staging and resetting T cell activation in SMACs. Nat Immunol. 2002;3:911\u20137. https:\/\/doi.org\/10.1038\/ni836.","journal-title":"Nat Immunol"},{"key":"8400_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1158\/2326-6066.CIR-14-0161","volume":"2","author":"ML Dustin","year":"2014","unstructured":"Dustin ML. The Immunological Synapse. Cancer Immunol Res. 2014;2:1023\u201333. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0161.","journal-title":"Cancer Immunol Res"},{"key":"8400_CR10","doi-asserted-by":"publisher","first-page":"eaaw8151","DOI":"10.1126\/scisignal.aaw8151","volume":"12","author":"AH Courtney","year":"2019","unstructured":"Courtney AH, Shvets AA, Lu W, Griffante G, Mollenauer M, Horkova V, et al. CD45 functions as a signaling gatekeeper in T cells. Sci Signal. 2019;12:eaaw8151. https:\/\/doi.org\/10.1126\/scisignal.aaw8151.","journal-title":"Sci Signal"},{"key":"8400_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/35053086","volume":"409","author":"J Irie-Sasaki","year":"2001","unstructured":"Irie-Sasaki J, Sasaki T, Matsumoto W, Opavsky A, Cheng M, Welstead G, et al. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature. 2001;409:349\u201354. https:\/\/doi.org\/10.1038\/35053086.","journal-title":"Nature"},{"key":"8400_CR12","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1084\/jem.20042294","volume":"201","author":"ND Huntington","year":"2005","unstructured":"Huntington ND, Xu Y, Nutt SL, Tarlinton DM. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells. J Exp Med. 2005;201:1421\u201333. https:\/\/doi.org\/10.1084\/jem.20042294.","journal-title":"J Exp Med"},{"key":"8400_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/352028a0","volume":"352","author":"M Merkenschlager","year":"1991","unstructured":"Merkenschlager M. Confusion over CD45 isoform. Nature. 1991;352:28\u201328. https:\/\/doi.org\/10.1038\/352028a0.","journal-title":"Nature"},{"key":"8400_CR14","doi-asserted-by":"publisher","first-page":"e0150434","DOI":"10.1371\/journal.pone.0150434","volume":"11","author":"E Krzywinska","year":"2016","unstructured":"Krzywinska E, Cornillon A, Allende-Vega N, Vo D-N, Rene C, Lu Z-Y, et al. CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity. PLoS ONE. 2016;11:e0150434. https:\/\/doi.org\/10.1371\/journal.pone.0150434.","journal-title":"PLoS ONE"},{"key":"8400_CR15","first-page":"85","volume":"50","author":"EZ Tchilian","year":"2002","unstructured":"Tchilian EZ, Beverley PCL. CD45 in memory and disease. Arch Immunol Ther Exp (Warsz). 2002;50:85\u201393.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"8400_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1517\/17425247.2015.966684","volume":"12","author":"MJ Mitchell","year":"2015","unstructured":"Mitchell MJ, King MR. Leukocytes as carriers for targeted cancer drug delivery. Expert Opin Drug Deliv. 2015;12:375\u201392. https:\/\/doi.org\/10.1517\/17425247.2015.966684.","journal-title":"Expert Opin Drug Deliv"},{"key":"8400_CR17","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.4049\/jimmunol.1302681","volume":"193","author":"AE Saunders","year":"2014","unstructured":"Saunders AE, Shim YA, Johnson P. Innate immune cell CD45 regulates lymphopenia-induced T cell proliferation. J Immunol Baltim Md 1950. 2014;193:2831\u201342. https:\/\/doi.org\/10.4049\/jimmunol.1302681.","journal-title":"J Immunol Baltim Md 1950"},{"key":"8400_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev.iy.12.040194.000505","volume":"12","author":"IS Trowbridge","year":"1994","unstructured":"Trowbridge IS, Thomas ML. CD45: An emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol. 1994;12:85\u2013116. https:\/\/doi.org\/10.1146\/annurev.iy.12.040194.000505.","journal-title":"Annu Rev Immunol"},{"key":"8400_CR19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/365156a0","volume":"365","author":"LML Chow","year":"1993","unstructured":"Chow LML, Fournel M, Davidson D, Veillette A. Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk. Nature. 1993;365:156\u201360. https:\/\/doi.org\/10.1038\/365156a0.","journal-title":"Nature"},{"key":"8400_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0092-8674(88)90053-0","volume":"55","author":"A Veillette","year":"1988","unstructured":"Veillette A, Bookman MA, Horak EM, Bolen JB. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. Cell. 1988;55:301\u20138. https:\/\/doi.org\/10.1016\/0092-8674(88)90053-0.","journal-title":"Cell"},{"key":"8400_CR21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0092-8674(92)90598-7","volume":"71","author":"AC Chan","year":"1992","unstructured":"Chan AC, Iwashima M, Turck CW, Weiss A. ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR \u03b6 chain. Cell. 1992;71:649\u201362. https:\/\/doi.org\/10.1016\/0092-8674(92)90598-7.","journal-title":"Cell"},{"key":"8400_CR22","doi-asserted-by":"publisher","first-page":"608747","DOI":"10.3389\/fcell.2020.608747","volume":"8","author":"P Castro-Sanchez","year":"2020","unstructured":"Castro-Sanchez P, Teagle AR, Prade S, Zamoyska R. Modulation of TCR Signaling by Tyrosine Phosphatases: From Autoimmunity to Immunotherapy. Front Cell Dev Biol. 2020;8:608747. https:\/\/doi.org\/10.3389\/fcell.2020.608747.","journal-title":"Front Cell Dev Biol"},{"key":"8400_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.immuni.2006.04.010","volume":"25","author":"R Varma","year":"2006","unstructured":"Varma R, Campi G, Yokosuka T, Saito T, Dustin ML. T Cell Receptor-Proximal Signals Are Sustained in Peripheral Microclusters and Terminated in the Central Supramolecular Activation Cluster. Immunity. 2006;25:117\u201327. https:\/\/doi.org\/10.1016\/j.immuni.2006.04.010.","journal-title":"Immunity"},{"key":"8400_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/25764","volume":"395","author":"CRF Monks","year":"1998","unstructured":"Monks CRF, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 1998;395:82\u20136. https:\/\/doi.org\/10.1038\/25764.","journal-title":"Nature"},{"key":"8400_CR25","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/ni.3392","volume":"17","author":"VT Chang","year":"2016","unstructured":"Chang VT, Fernandes RA, Ganzinger KA, Lee SF, Siebold C, McColl J, et al. Initiation of T cell signaling by CD45 segregation at \u2018close-contacts\u2019. Nat Immunol. 2016;17:574\u201382. https:\/\/doi.org\/10.1038\/ni.3392.","journal-title":"Nat Immunol"},{"key":"8400_CR26","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.4049\/jimmunol.158.3.1458","volume":"158","author":"MM Maurice","year":"1997","unstructured":"Maurice MM, Nakamura H, van der Voort EA, van Vliet AI, Staal FJ, Tak PP, et al. Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol. 1997;158:1458\u201365. https:\/\/doi.org\/10.4049\/jimmunol.158.3.1458.","journal-title":"J Immunol"},{"key":"8400_CR27","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/eji.1830250612","volume":"25","author":"ME Allen","year":"1995","unstructured":"Allen ME, Young SP, Michell RH, Bacon PA. Altered T lymphocyte signaling in rheumatoid arthritis. Eur J Immunol. 1995;25:1547\u201354. https:\/\/doi.org\/10.1002\/eji.1830250612.","journal-title":"Eur J Immunol"},{"key":"8400_CR28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2249.2007.03508.x","volume":"150","author":"A Windhagen","year":"2007","unstructured":"Windhagen A, S\u00f6nmez D, Hornig-Do HT, Kalinowsky A, Schwinzer R. Altered CD45 isoform expression in C77G carriers influences cytokine responsiveness and adhesion properties of T cells. Clin Exp Immunol. 2007;150:509\u201317. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03508.x.","journal-title":"Clin Exp Immunol"},{"key":"8400_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/sj.gene.6363894","volume":"4","author":"R Schwinzer","year":"2003","unstructured":"Schwinzer R, Witte T, Hundrieser J, Ehlers S, Momot T, Hunzelmann N, et al. Enhanced frequency of a PTPRC (CD45) exon A mutation (77\u00a0C\u2192G) in systemic sclerosis. Genes Immun. 2003;4:168\u20139. https:\/\/doi.org\/10.1038\/sj.gene.6363894.","journal-title":"Genes Immun"},{"key":"8400_CR30","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/jmg.2005.040485","volume":"43","author":"R Dawes","year":"2006","unstructured":"Dawes R, Hennig B, Irving W, Petrova S, Boxall S, Ward V, et al. Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection. J Med Genet. 2006;43:678\u201384. https:\/\/doi.org\/10.1136\/jmg.2005.040485.","journal-title":"J Med Genet"},{"key":"8400_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.gene.6363918","volume":"4","author":"A Vogel","year":"2003","unstructured":"Vogel A, Strassburg CP, Manns MP. 77\u00a0C\/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link. Genes Immun. 2003;4:79\u201381. https:\/\/doi.org\/10.1038\/sj.gene.6363918.","journal-title":"Genes Immun"},{"key":"8400_CR32","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1097\/00002030-200109280-00024","volume":"15","author":"EZ Tchilian","year":"2001","unstructured":"Tchilian EZ, Wallace DL, Dawes R, Imami N, Burton C, Gotch F, et al. A point mutation in CD45 may be associated with an increased risk of HIV-1 infection. AIDS. 2001;15:1892\u20134. https:\/\/doi.org\/10.1097\/00002030-200109280-00024.","journal-title":"AIDS"},{"key":"8400_CR33","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1182\/blood-2003-03-0716","volume":"103","author":"P Shrivastava","year":"2004","unstructured":"Shrivastava P, Katagiri T, Ogimoto M, Mizuno K, Yakura H. Dynamic regulation of Src-family kinases by CD45 in B cells. Blood. 2004;103:1425\u201332. https:\/\/doi.org\/10.1182\/blood-2003-03-0716.","journal-title":"Blood"},{"key":"8400_CR34","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1126\/science.1648262","volume":"252","author":"LB Justement","year":"1991","unstructured":"Justement LB, Campbell KS, Chien NC, Cambier JC. Regulation of B Cell Antigen Receptor Signal Transduction and Phosphorylation by CD45. Science. 1991;252:1839\u201342. https:\/\/doi.org\/10.1126\/science.1648262.","journal-title":"Science"},{"key":"8400_CR35","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.4049\/jimmunol.163.3.1321","volume":"163","author":"T Katagiri","year":"1999","unstructured":"Katagiri T, Ogimoto M, Hasegawa K, Arimura Y, Mitomo K, Okada M, et al. CD45 Negatively Regulates Lyn Activity by Dephosphorylating Both Positive and Negative Regulatory Tyrosine Residues in Immature B Cells1. J Immunol. 1999;163:1321\u20136. https:\/\/doi.org\/10.4049\/jimmunol.163.3.1321.","journal-title":"J Immunol"},{"key":"8400_CR36","doi-asserted-by":"publisher","first-page":"30487","DOI":"10.1074\/jbc.271.48.30487","volume":"271","author":"S Yanagi","year":"1996","unstructured":"Yanagi S, Sugawara H, Kurosaki M, Sabe H, Yamamura H, Kurosaki T. CD45 Modulates Phosphorylation of Both Autophosphorylation and Negative Regulatory Tyrosines of Lyn in B Cells *. J Biol Chem. 1996;271:30487\u201392. https:\/\/doi.org\/10.1074\/jbc.271.48.30487.","journal-title":"J Biol Chem"},{"key":"8400_CR37","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.1038\/s41467-021-23792-8","volume":"12","author":"Y Jung","year":"2021","unstructured":"Jung Y, Wen L, Altman A, Ley K. CD45 pre-exclusion from the tips of T cell microvilli prior to antigen recognition. Nat Commun. 2021;12:3872. https:\/\/doi.org\/10.1038\/s41467-021-23792-8.","journal-title":"Nat Commun"},{"key":"8400_CR38","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.4049\/jimmunol.158.6.2663","volume":"158","author":"LI Pao","year":"1997","unstructured":"Pao LI, Cambier JC. Syk, but not Lyn, recruitment to B cell antigen receptor and activation following stimulation of CD45- B cells. J Immunol. 1997;158:2663\u20139. https:\/\/doi.org\/10.4049\/jimmunol.158.6.2663.","journal-title":"J Immunol"},{"key":"8400_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s1074-7613(00)80591-9","volume":"9","author":"C Fu","year":"1998","unstructured":"Fu C, Turck CW, Kurosaki T, Chan AC. BLNK: a central linker protein in B cell activation. Immunity. 1998;9:93\u2013103. https:\/\/doi.org\/10.1016\/s1074-7613(00)80591-9.","journal-title":"Immunity"},{"key":"8400_CR40","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1146\/annurev.immunol.17.1.555","volume":"17","author":"T Kurosaki","year":"1999","unstructured":"Kurosaki T, GENETIC ANALYSIS OF B CELL ANTIGEN, RECEPTOR SIGNALING. Annu Rev Immunol. 1999;17:555\u201392. https:\/\/doi.org\/10.1146\/annurev.immunol.17.1.555.","journal-title":"Annu Rev Immunol"},{"key":"8400_CR41","doi-asserted-by":"publisher","first-page":"16174","DOI":"10.1074\/jbc.M909044199","volume":"275","author":"BS Gaul","year":"2000","unstructured":"Gaul BS, Harrison ML, Geahlen RL, Burton RA, Post CB. Substrate recognition by the Lyn protein-tyrosine kinase. NMR structure of the immunoreceptor tyrosine-based activation motif signaling region of the B cell antigen receptor. J Biol Chem. 2000;275:16174\u201382. https:\/\/doi.org\/10.1074\/jbc.M909044199.","journal-title":"J Biol Chem"},{"key":"8400_CR42","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1182\/blood-2012-06-438234","volume":"120","author":"MC Clark","year":"2012","unstructured":"Clark MC, Pang M, Hsu DK, Liu F-T, de Vos S, Gascoyne RD, et al. Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death. Blood. 2012;120:4635\u201344. https:\/\/doi.org\/10.1182\/blood-2012-06-438234.","journal-title":"Blood"},{"key":"8400_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10863-006-9063-9","volume":"39","author":"P Nangia-Makker","year":"2007","unstructured":"Nangia-Makker P, Nakahara S, Hogan V, Raz A. Galectin-3 in apoptosis, a novel therapeutic target. J Bioenerg Biomembr. 2007;39:79\u201384. https:\/\/doi.org\/10.1007\/s10863-006-9063-9.","journal-title":"J Bioenerg Biomembr"},{"key":"8400_CR44","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0002-9440(10)63177-X","volume":"164","author":"KK Hoyer","year":"2004","unstructured":"Hoyer KK, Pang M, Gui D, Shintaku IP, Kuwabara I, Liu F-T, et al. An Anti-Apoptotic Role for Galectin-3 in Diffuse Large B-Cell Lymphomas. Am J Pathol. 2004;164:893\u2013902. https:\/\/doi.org\/10.1016\/S0002-9440(10)63177-X.","journal-title":"Am J Pathol"},{"key":"8400_CR45","doi-asserted-by":"publisher","unstructured":"Ma S, Mussbacher M, Moriarty A, Keeter WC, Gauronskas P, Waseem T, et al. CD45-dependent regulation of B cell receptor signaling in atherosclerosis. J Immunol. 2021;206:95.03. https:\/\/doi.org\/10.4049\/jimmunol.206.Supp.","DOI":"10.4049\/jimmunol.206.Supp"},{"key":"8400_CR46","doi-asserted-by":"publisher","first-page":"eabe2740","DOI":"10.1126\/scisignal.abe2740","volume":"14","author":"Q Verron","year":"2021","unstructured":"Verron Q, Forslund E, Brandt L, Leino M, Frisk TW, Olofsson PE, et al. NK cells integrate signals over large areas when building immune synapses but require local stimuli for degranulation. Sci Signal. 2021;14:eabe2740. https:\/\/doi.org\/10.1126\/scisignal.abe2740.","journal-title":"Sci Signal"},{"key":"8400_CR47","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev.immunol.20.092601.111357","volume":"20","author":"LE Samelson","year":"2002","unstructured":"Samelson LE. Signal Transduction Mediated by the T Cell Antigen Receptor: The Role of Adapter Proteins*. Annu Rev Immunol. 2002;20:371\u201394. https:\/\/doi.org\/10.1146\/annurev.immunol.20.092601.111357.","journal-title":"Annu Rev Immunol"},{"key":"8400_CR48","doi-asserted-by":"publisher","first-page":"7012","DOI":"10.1073\/pnas.0601851103","volume":"103","author":"DGT Hesslein","year":"2006","unstructured":"Hesslein DGT, Takaki R, Hermiston ML, Weiss A, Lanier LL. Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc Natl Acad Sci. 2006;103:7012\u20137. https:\/\/doi.org\/10.1073\/pnas.0601851103.","journal-title":"Proc Natl Acad Sci"},{"key":"8400_CR49","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0952-7915(03)00039-6","volume":"15","author":"LL Lanier","year":"2003","unstructured":"Lanier LL. Natural killer cell receptor signaling. Curr Opin Immunol. 2003;15:308\u201314. https:\/\/doi.org\/10.1016\/S0952-7915(03)00039-6.","journal-title":"Curr Opin Immunol"},{"key":"8400_CR50","doi-asserted-by":"publisher","first-page":"6437057","DOI":"10.1155\/2020\/6437057","volume":"2020","author":"Y Chen","year":"2020","unstructured":"Chen Y, Lu D, Churov A, Fu R. Research Progress on NK Cell Receptors and Their Signaling Pathways. Mediators Inflamm. 2020;2020:6437057. https:\/\/doi.org\/10.1155\/2020\/6437057.","journal-title":"Mediators Inflamm"},{"key":"8400_CR51","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1182\/blood-2010-06-292219","volume":"117","author":"DGT Hesslein","year":"2011","unstructured":"Hesslein DGT, Palacios EH, Sun JC, Beilke JN, Watson SR, Weiss A, et al. Differential requirements for CD45 in NK-cell function reveal distinct roles for Syk-family kinases. Blood. 2011;117:3087\u201395. https:\/\/doi.org\/10.1182\/blood-2010-06-292219.","journal-title":"Blood"},{"key":"8400_CR52","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"CAJ Medzhitov Jr","year":"2002","unstructured":"Medzhitov CAJ Jr. Innate Immune Recognition. Annu Rev Immunol. 2002;20:197\u2013216. https:\/\/doi.org\/10.1146\/annurev.immunol.20.083001.084359.","journal-title":"Annu Rev Immunol"},{"key":"8400_CR53","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1365-2567.2006.02363.x","volume":"118","author":"J Piercy","year":"2006","unstructured":"Piercy J, Petrova S, Tchilian EZ, Beverley PCL. CD45 negatively regulates tumour necrosis factor and interleukin-6 production in dendritic cells. Immunology. 2006;118:250\u20136. https:\/\/doi.org\/10.1111\/j.1365-2567.2006.02363.x.","journal-title":"Immunology"},{"key":"8400_CR54","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3892\/ol.2014.2161","volume":"8","author":"D-E Cheng","year":"2014","unstructured":"Cheng D-E, Tsai Y-M, Hsu Y-L, Hou M-F, Tsai E-M, Wang J-Y, et al. Cluster of differentiation 45 activation is crucial in interleukin-10-dependent tumor-associated dendritic cell differentiation. Oncol Lett. 2014;8:620\u20136. https:\/\/doi.org\/10.3892\/ol.2014.2161.","journal-title":"Oncol Lett"},{"key":"8400_CR55","doi-asserted-by":"publisher","first-page":"8020","DOI":"10.4049\/jimmunol.180.12.8020","volume":"180","author":"JL Cross","year":"2008","unstructured":"Cross JL, Kott K, Mileti\u0107 T, Johnson P. CD45 Regulates TLR-Induced Proinflammatory Cytokine and IFN-\u03b2 Secretion in Dendritic Cells1. J Immunol. 2008;180:8020\u20139. https:\/\/doi.org\/10.4049\/jimmunol.180.12.8020.","journal-title":"J Immunol"},{"key":"8400_CR56","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1084\/jem.178.3.1017","volume":"178","author":"BK English","year":"1993","unstructured":"English BK, Ihle JN, Myracle A, Yi T. Hck tyrosine kinase activity modulates tumor necrosis factor production by murine macrophages. J Exp Med. 1993;178:1017\u201322. https:\/\/doi.org\/10.1084\/jem.178.3.1017.","journal-title":"J Exp Med"},{"key":"8400_CR57","first-page":"3488","volume":"154","author":"Y Zaffran","year":"1995","unstructured":"Zaffran Y, Escallier JC, Ruta S, Capo C, Mege JL. Zymosan-triggered association of tyrosine phosphoproteins and lyn kinase with cytoskeleton in human monocytes. J Immunol Baltim Md 1950. 1995;154:3488\u201397.","journal-title":"J Immunol Baltim Md 1950"},{"key":"8400_CR58","first-page":"849","volume":"7","author":"U Lichtenberg","year":"1992","unstructured":"Lichtenberg U, Quintrell N, Bishop JM. Human protein-tyrosine kinase gene HCK: expression and structural analysis of the promoter region. Oncogene. 1992;7:849\u201358.","journal-title":"Oncogene"},{"key":"8400_CR59","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3389\/fimmu.2020.00738","volume":"11","author":"A Torres-Gomez","year":"2020","unstructured":"Torres-Gomez A, Caba\u00f1as C, Lafuente EM. Phagocytic Integrins: Activation and Signaling. Front Immunol. 2020;11:738. https:\/\/doi.org\/10.3389\/fimmu.2020.00738.","journal-title":"Front Immunol"},{"key":"8400_CR60","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1073\/pnas.90.4.1402","volume":"90","author":"ED Cahir McFarland","year":"1993","unstructured":"Cahir McFarland ED, Hurley TR, Pingel JT, Sefton BM, Shaw A, Thomas ML. Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor. Proc Natl Acad Sci U S A. 1993;90:1402\u20136. https:\/\/doi.org\/10.1073\/pnas.90.4.1402.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8400_CR61","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1002\/j.1460-2075.1992.tb05595.x","volume":"11","author":"M Shiroo","year":"1992","unstructured":"Shiroo M, Goff L, Biffen M, Shivnan E, Alexander D. CD45 tyrosine phosphatase-activated p59fyn couples the T cell antigen receptor to pathways of diacylglycerol production, protein kinase C activation and calcium influx. EMBO J. 1992;11:4887\u201397. https:\/\/doi.org\/10.1002\/j.1460-2075.1992.tb05595.x.","journal-title":"EMBO J"},{"key":"8400_CR62","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/j.1460-2075.1993.tb05659.x","volume":"12","author":"M Sieh","year":"1993","unstructured":"Sieh M, Bolen JB, Weiss A. CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. EMBO J. 1993;12:315\u201321. https:\/\/doi.org\/10.1002\/j.1460-2075.1993.tb05659.x.","journal-title":"EMBO J"},{"key":"8400_CR63","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0960-9822(06)00188-6","volume":"7","author":"T Roach","year":"1997","unstructured":"Roach T, Slater S, Koval M, White L, McFarland EC, Okumura M, et al. CD45 regulates Src family member kinase activity associated with macrophage integrin-mediated adhesion. Curr Biol. 1997;7:408\u201317. https:\/\/doi.org\/10.1016\/S0960-9822(06)00188-6.","journal-title":"Curr Biol"},{"key":"8400_CR64","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.immuni.2016.01.014","volume":"44","author":"V Kumar","year":"2016","unstructured":"Kumar V, Cheng P, Condamine T, Mony S, Languino LR, McCaffrey JC, et al. CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation. Immunity. 2016;44:303\u201315. https:\/\/doi.org\/10.1016\/j.immuni.2016.01.014.","journal-title":"Immunity"},{"key":"8400_CR65","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1111\/febs.15803","volume":"289","author":"A Othman","year":"2022","unstructured":"Othman A, Sekheri M, Filep JG. Roles of neutrophil granule proteins in orchestrating inflammation and immunity. FEBS J. 2022;289:3932\u201353. https:\/\/doi.org\/10.1111\/febs.15803.","journal-title":"FEBS J"},{"key":"8400_CR66","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/87687","volume":"2","author":"JM Penninger","year":"2001","unstructured":"Penninger JM, Irie-Sasaki J, Sasaki T, Oliveira-dos-Santos AJ. CD45: new jobs for an old acquaintance. Nat Immunol. 2001;2:389\u201396. https:\/\/doi.org\/10.1038\/87687.","journal-title":"Nat Immunol"},{"key":"8400_CR67","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.immuni.2011.09.011","volume":"35","author":"JW Zhu","year":"2011","unstructured":"Zhu JW, Doan K, Park J, Chau AH, Zhang H, Lowell CA, et al. Distinct functions of receptor-like tyrosine phosphatases CD45 and CD148 in chemoattractant-mediated neutrophil migration and response to S. aureus infection. Immunity. 2011;35:757\u201369. https:\/\/doi.org\/10.1016\/j.immuni.2011.09.011.","journal-title":"Immunity"},{"key":"8400_CR68","first-page":"2175","volume":"155","author":"WC Liles","year":"1995","unstructured":"Liles WC, Ledbetter JA, Waltersdorph AW, Klebanoff SJ. Cross-linking of CD45 enhances activation of the respiratory burst in response to specific stimuli in human phagocytes. J Immunol Baltim Md 1950. 1995;155:2175\u201384.","journal-title":"J Immunol Baltim Md 1950"},{"key":"8400_CR69","first-page":"949","volume":"146","author":"L Harvath","year":"1991","unstructured":"Harvath L, Balke JA, Christiansen NP, Russell AA, Skubitz KM. Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis. J Immunol Baltim Md 1950. 1991;146:949\u201357.","journal-title":"J Immunol Baltim Md 1950"},{"key":"8400_CR70","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.3324\/haematol.2019.225722","volume":"105","author":"I Rohwedder","year":"2020","unstructured":"Rohwedder I, Kurz ARM, Pruenster M, Immler R, Pick R, Eggersmann T, et al. Src family kinase-mediated vesicle trafficking is critical for neutrophil basement membrane penetration. Haematologica. 2020;105:1845\u201356. https:\/\/doi.org\/10.3324\/haematol.2019.225722.","journal-title":"Haematologica"},{"key":"8400_CR71","doi-asserted-by":"publisher","first-page":"728","DOI":"10.4049\/jimmunol.1401646","volume":"194","author":"G Germena","year":"2015","unstructured":"Germena G, Volmering S, Sohlbach C, Zarbock A. Mutation in the CD45 inhibitory wedge modulates integrin activation and leukocyte recruitment during inflammation. J Immunol Baltim Md 1950. 2015;194:728\u201338. https:\/\/doi.org\/10.4049\/jimmunol.1401646.","journal-title":"J Immunol Baltim Md 1950"},{"key":"8400_CR72","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/jjco\/hyp088","volume":"39","author":"M Danbara","year":"2009","unstructured":"Danbara M, Yoshida M, Kanoh Y, Jiang S-X, Masuda N, Akahoshi T, et al. Flow cytometric detection of small cell lung cancer cells with aberrant CD45 expression in micrometastatic bone marrow. Jpn J Clin Oncol. 2009;39:771\u20135. https:\/\/doi.org\/10.1093\/jjco\/hyp088.","journal-title":"Jpn J Clin Oncol"},{"key":"8400_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01789-1","volume":"9","author":"C Yang","year":"2024","unstructured":"Yang C, Wang X, To KKW, Cui C, Luo M, Wu S, et al. Circulating tumor cells shielded with extracellular vesicle-derived CD45 evade T cell attack to enable metastasis. Signal Transduct Target Ther. 2024;9:1\u201318. https:\/\/doi.org\/10.1038\/s41392-024-01789-1.","journal-title":"Signal Transduct Target Ther"},{"key":"8400_CR74","doi-asserted-by":"publisher","first-page":"e2110241118","DOI":"10.1073\/pnas.2110241118","volume":"118","author":"JH Shin","year":"2021","unstructured":"Shin JH, Jeong J, Maher SE, Lee H-W, Lim J, Bothwell ALM. Colon cancer cells acquire immune regulatory molecules from tumor-infiltrating lymphocytes by trogocytosis. Proc Natl Acad Sci U S A. 2021;118:e2110241118. https:\/\/doi.org\/10.1073\/pnas.2110241118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8400_CR75","doi-asserted-by":"publisher","first-page":"8755","DOI":"10.7150\/thno.63446","volume":"11","author":"S-Y Park","year":"2021","unstructured":"Park S-Y, Kim J-Y, Jang G-B, Choi J-H, Kim J-H, Lee C-J, et al. Aberrant activation of the CD45-Wnt signaling axis promotes stemness and therapy resistance in colorectal cancer cells. Theranostics. 2021;11:8755\u201370. https:\/\/doi.org\/10.7150\/thno.63446.","journal-title":"Theranostics"},{"key":"8400_CR76","doi-asserted-by":"publisher","first-page":"104130","DOI":"10.1016\/j.cellimm.2020.104130","volume":"353","author":"A Bhatta","year":"2020","unstructured":"Bhatta A, Chan MA, Benedict SH. Engagement of CD45 alters early signaling events in human T cells co-stimulated through TCR\u2009+\u2009CD28. Cell Immunol. 2020;353:104130. https:\/\/doi.org\/10.1016\/j.cellimm.2020.104130.","journal-title":"Cell Immunol"},{"key":"8400_CR77","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2007.07.015","volume":"27","author":"L McNeill","year":"2007","unstructured":"McNeill L, Salmond RJ, Cooper JC, Carret CK, Cassady-Cain RL, Roche-Molina M, et al. The Differential Regulation of Lck Kinase Phosphorylation Sites by CD45 Is Critical for T Cell Receptor Signaling Responses. Immunity. 2007;27:425\u201337. https:\/\/doi.org\/10.1016\/j.immuni.2007.07.015.","journal-title":"Immunity"},{"key":"8400_CR78","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1038\/mtna.2011.3","volume":"1","author":"TI Novobrantseva","year":"2012","unstructured":"Novobrantseva TI, Borodovsky A, Wong J, Klebanov B, Zafari M, Yucius K, et al. Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells. Mol Ther - Nucleic Acids. 2012;1:e4. https:\/\/doi.org\/10.1038\/mtna.2011.3.","journal-title":"Mol Ther - Nucleic Acids"},{"key":"8400_CR79","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1084\/jem.20041890","volume":"201","author":"H-J Nam","year":"2005","unstructured":"Nam H-J, Poy F, Saito H, Frederick CA. Structural basis for the function and regulation of the receptor protein tyrosine phosphatase CD45. J Exp Med. 2005;201:441\u201352. https:\/\/doi.org\/10.1084\/jem.20041890.","journal-title":"J Exp Med"},{"key":"8400_CR80","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev.iy.07.040189.002011","volume":"7","author":"ML Thomas","year":"1989","unstructured":"Thomas ML. The Leukocyte Common Antigen Family. Annu Rev Immunol. 1989;7:339\u201369. https:\/\/doi.org\/10.1146\/annurev.iy.07.040189.002011.","journal-title":"Annu Rev Immunol"},{"key":"8400_CR81","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/382555a0","volume":"382","author":"AM Bilwes","year":"1996","unstructured":"Bilwes AM, Den Hertog J, Hunter T, Noel JP. Structural basis for inhibition of receptor protein-tyrosine phosphatase-\u03b1 by dimerization. Nature. 1996;382:555\u20139. https:\/\/doi.org\/10.1038\/382555a0.","journal-title":"Nature"},{"key":"8400_CR82","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1073\/pnas.86.17.6734","volume":"86","author":"ML Birkeland","year":"1989","unstructured":"Birkeland ML, Johnson P, Trowbridge IS, Pur\u00e9 E. Changes in CD45 isoform expression accompany antigen-induced murine T-cell activation. Proc Natl Acad Sci. 1989;86:6734\u20138. https:\/\/doi.org\/10.1073\/pnas.86.17.6734.","journal-title":"Proc Natl Acad Sci"},{"key":"8400_CR83","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1002\/eji.1830270838","volume":"27","author":"DL Farber","year":"1997","unstructured":"Farber DL, Acuto O, Bottomly K. Differential T cell receptor-mediated signaling in naive and memory CD4 T cells. Eur J Immunol. 1997;27:2094\u2013101. https:\/\/doi.org\/10.1002\/eji.1830270838.","journal-title":"Eur J Immunol"},{"key":"8400_CR84","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1002\/(SICI)1521-4141(199907)29:07<2098","volume":"29","author":"SR Hall","year":"1999","unstructured":"Hall SR, Heffernan BM, Thompson NT, Rowan WC. CD4\u2009+\u2009CD45RA\u2009+\u2009and CD4\u2009+\u2009CD45RO\u2009+\u2009T cells differ in their TCR-associated signaling responses. Eur J Immunol. 1999;29:2098\u2013106. https:\/\/doi.org\/10.1002\/(SICI)1521-4141(199907)29:07%3C2098. :AID-IMMU2098>3.0.CO;2-B.","journal-title":"Eur J Immunol"},{"key":"8400_CR85","doi-asserted-by":"publisher","first-page":"eabl3995","DOI":"10.1126\/sciimmunol.abl3995","volume":"7","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, Zhang X, Tu L, Cao J, Hinrichs CS, Su X. Size-dependent activation of CAR-T cells. Sci Immunol. 2022;7:eabl3995. https:\/\/doi.org\/10.1126\/sciimmunol.abl3995.","journal-title":"Sci Immunol"},{"key":"8400_CR86","doi-asserted-by":"publisher","first-page":"eadi1145","DOI":"10.1126\/scitranslmed.adi1145","volume":"15","author":"N Wellhausen","year":"2023","unstructured":"Wellhausen N, O\u2019Connell RP, Lesch S, Engel NW, Rennels AK, Gonzales D, et al. Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapy. Sci Transl Med. 2023;15:eadi1145. https:\/\/doi.org\/10.1126\/scitranslmed.adi1145.","journal-title":"Sci Transl Med"},{"key":"8400_CR87","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41586-024-07456-3","volume":"630","author":"S Garaud\u00e9","year":"2024","unstructured":"Garaud\u00e9 S, Marone R, Lepore R, Devaux A, Beerlage A, Seyres D, et al. Selective haematological cancer eradication with preserved haematopoiesis. Nature. 2024;630:728\u201335. https:\/\/doi.org\/10.1038\/s41586-024-07456-3.","journal-title":"Nature"},{"key":"8400_CR88","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.1021\/jacs.3c13966","volume":"146","author":"Y-H Ma","year":"2024","unstructured":"Ma Y-H, Zhu Y, Wu H, He Y, Zhang Q, Huang Q, et al. Domain-Targeted Membrane Partitioning of Specific Proteins with DNA Nanodevices. J Am Chem Soc. 2024;146:7640\u20138. https:\/\/doi.org\/10.1021\/jacs.3c13966.","journal-title":"J Am Chem Soc"},{"key":"8400_CR89","doi-asserted-by":"publisher","first-page":"22445","DOI":"10.1021\/jacs.4c05665","volume":"146","author":"S Wu","year":"2024","unstructured":"Wu S, Shang Y, Yan Y, Zhou A, Bing T, Zhao Z, et al. Aptamer-Based Enforced Phosphatase-Recruiting Chimeras Inhibit Receptor Tyrosine Kinase Signal Transduction. J Am Chem Soc. 2024;146:22445\u201354. https:\/\/doi.org\/10.1021\/jacs.4c05665.","journal-title":"J Am Chem Soc"},{"key":"8400_CR90","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41586-020-2851-2","volume":"586","author":"RA Fernandes","year":"2020","unstructured":"Fernandes RA, Su L, Nishiga Y, Ren J, Bhuiyan AM, Cheng N, et al. Immune receptor inhibition through enforced phosphatase recruitment. Nature. 2020;586:779\u201384. https:\/\/doi.org\/10.1038\/s41586-020-2851-2.","journal-title":"Nature"},{"key":"8400_CR91","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1021\/acssynbio.2c00337","volume":"11","author":"J Ren","year":"2022","unstructured":"Ren J, Jo Y, Picton LK, Su LL, Raulet DH, Garcia KC. Induced CD45 Proximity Potentiates Natural Killer Cell Receptor Antagonism. ACS Synth Biol. 2022;11:3426\u201339. https:\/\/doi.org\/10.1021\/acssynbio.2c00337.","journal-title":"ACS Synth Biol"},{"key":"8400_CR92","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.immuni.2024.01.007","volume":"57","author":"AH Lippert","year":"2024","unstructured":"Lippert AH, Paluch C, Gaglioni M, Vuong MT, McColl J, Jenkins E, et al. Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases. Immunity. 2024;57:256\u2013e27010. https:\/\/doi.org\/10.1016\/j.immuni.2024.01.007.","journal-title":"Immunity"},{"key":"8400_CR93","doi-asserted-by":"publisher","unstructured":"Deacy AM, Gan SK-E, Derrick JP. Superantigen recognition and interactions: functions, mechanisms and applications. Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.731845.","DOI":"10.3389\/fimmu.2021.731845"},{"key":"8400_CR94","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.ymthe.2024.03.032","volume":"32","author":"J Yeung","year":"2024","unstructured":"Yeung J, Liao A, Shaw M, Silva S, Vetharoy W, Rico DL, et al. Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant. Mol Ther. 2024;32:1672\u201386. https:\/\/doi.org\/10.1016\/j.ymthe.2024.03.032.","journal-title":"Mol Ther"},{"key":"8400_CR95","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1182\/blood-2018-99-119432","volume":"132","author":"R Palchaudhuri","year":"2018","unstructured":"Palchaudhuri R, Hyzy SL, Proctor JL, Adams HL, Pearse BR, Sarma G, et al. Antibody Drug Conjugates Targeted to CD45 or CD117 Enable Allogeneic Hematopoietic Stem Cell Transplantation in Animal Models. Blood. 2018;132:3324\u20133324. https:\/\/doi.org\/10.1182\/blood-2018-99-119432.","journal-title":"Blood"},{"key":"8400_CR96","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1182\/blood-2019-130752","volume":"134","author":"GO Gillard","year":"2019","unstructured":"Gillard GO, Proctor JL, Brooks ML, Lamothe TL, Hyzy SL, Mikse O, et al. A Novel Targeted Approach to Achieve Immune System Reset: CD45-Targeted Antibody Drug Conjugates Enable Autologous HSCT, Ameliorate Disease in Autoimmune Models, Potently Kill Human Immune Cells from Normal Donors and MS Patients, and Achieve Immune Depletion in Non-Human Primates (NHP). Blood. 2019;134:3208\u20133208. https:\/\/doi.org\/10.1182\/blood-2019-130752.","journal-title":"Blood"},{"key":"8400_CR97","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1182\/bloodadvances.2023010561","volume":"7","author":"K Gustafsson","year":"2023","unstructured":"Gustafsson K, Rhee C, Frodermann V, Scadden EW, Li D, Iwamoto Y, et al. Clearing and replacing tissue-resident myeloid cells with an anti-CD45 antibody\u2013drug conjugate. Blood Adv. 2023;7:6964\u201373. https:\/\/doi.org\/10.1182\/bloodadvances.2023010561.","journal-title":"Blood Adv"},{"key":"8400_CR98","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12967-022-03350-6","volume":"20","author":"L Navarrete-Galvan","year":"2022","unstructured":"Navarrete-Galvan L, Guglielmo M, Cruz Amaya J, Smith-Gagen J, Lombardi VC, Merica R, et al. Optimizing NK-92 serial killers: gamma irradiation, CD95\/Fas-ligation, and NK or LAK attack limit cytotoxic efficacy. J Transl Med. 2022;20:151. https:\/\/doi.org\/10.1186\/s12967-022-03350-6.","journal-title":"J Transl Med"},{"key":"8400_CR99","doi-asserted-by":"publisher","first-page":"6932","DOI":"10.1158\/1078-0432.CCR-19-1567","volume":"25","author":"RD Cassaday","year":"2019","unstructured":"Cassaday RD, Press OW, Pagel JM, Rajendran JG, Gooley TA, Fisher DR, et al. Phase I Study of a CD45-Targeted Antibody\u2013Radionuclide Conjugate for High-Risk Lymphoma. Clin Cancer Res. 2019;25:6932\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-1567.","journal-title":"Clin Cancer Res"},{"key":"8400_CR100","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3324\/haematol.2019.229492","volume":"105","author":"P Vo","year":"2020","unstructured":"Vo P, Gooley TA, Rajendran JG, Fisher DR, Orozco JJ, Green DJ, et al. Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed\/refractory leukemia or myelodysplasia. Haematologica. 2020;105:1731\u20137. https:\/\/doi.org\/10.3324\/haematol.2019.229492.","journal-title":"Haematologica"},{"key":"8400_CR101","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00062752-200207000-00009","volume":"9","author":"ER Nemecek","year":"2002","unstructured":"Nemecek ER, Matthews DC. Antibody-based therapy of human leukemia. Curr Opin Hematol. 2002;9:316.","journal-title":"Curr Opin Hematol"},{"key":"8400_CR102","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1182\/blood-2011-04-347039","volume":"118","author":"JM Pagel","year":"2011","unstructured":"Pagel JM, Kenoyer AL, B\u00e4ck T, Hamlin DK, Wilbur DS, Fisher DR, et al. Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model. Blood. 2011;118:703\u201311. https:\/\/doi.org\/10.1182\/blood-2011-04-347039.","journal-title":"Blood"},{"key":"8400_CR103","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1182\/blood-2012-11-467035","volume":"121","author":"JJ Orozco","year":"2013","unstructured":"Orozco JJ, B\u00e4ck T, Kenoyer A, Balkin ER, Hamlin DK, Wilbur DS, et al. Anti-CD45 radioimmunotherapy using 211At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model. Blood. 2013;121:3759\u201367. https:\/\/doi.org\/10.1182\/blood-2012-11-467035.","journal-title":"Blood"},{"key":"8400_CR104","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/j.1742-4658.2012.08718.x","volume":"280","author":"R He","year":"2013","unstructured":"He R, Zeng L-F, He Y, Zhang S, Zhang Z-Y. Small molecule tools for functional interrogation of protein tyrosine phosphatases. FEBS J. 2013;280:731\u201350. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08718.x.","journal-title":"FEBS J"},{"key":"8400_CR105","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41586-024-08441-6","volume":"639","author":"A Salehi Farid","year":"2025","unstructured":"Salehi Farid A, Rowley JE, Allen HH, Kruger IG, Tavakolpour S, Neeley K, et al. CD45-PET is a robust, non-invasive tool for imaging inflammation. Nature. 2025;639:214\u201324. https:\/\/doi.org\/10.1038\/s41586-024-08441-6.","journal-title":"Nature"},{"key":"8400_CR106","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1021\/acsnano.7b00078","volume":"11","author":"Y Zheng","year":"2017","unstructured":"Zheng Y, Tang L, Mabardi L, Kumari S, Irvine DJ. Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Non-Internalizing Receptors. ACS Nano. 2017;11:3089\u2013100. https:\/\/doi.org\/10.1021\/acsnano.7b00078.","journal-title":"ACS Nano"},{"key":"8400_CR107","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/s41590-024-01925-7","volume":"25","author":"L Santollani","year":"2024","unstructured":"Santollani L, Maiorino L, Zhang YJ, Palmeri JR, Stinson JA, Duhamel LR, et al. Local delivery of cell surface-targeted immunocytokines programs systemic antitumor immunity. Nat Immunol. 2024;25:1820\u20139. https:\/\/doi.org\/10.1038\/s41590-024-01925-7.","journal-title":"Nat Immunol"},{"key":"8400_CR108","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nm.2198","volume":"16","author":"MT Stephan","year":"2010","unstructured":"Stephan MT, Moon JJ, Um SH, Bershteyn A, Irvine DJ. Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat Med. 2010;16:1035\u201341. https:\/\/doi.org\/10.1038\/nm.2198.","journal-title":"Nat Med"},{"key":"8400_CR109","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1016\/j.biomaterials.2012.04.029","volume":"33","author":"MT Stephan","year":"2012","unstructured":"Stephan MT, Stephan SB, Bak P, Chen J, Irvine DJ. Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles. Biomaterials. 2012;33:5776\u201387. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.04.029.","journal-title":"Biomaterials"},{"key":"8400_CR110","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nbt.4181","volume":"36","author":"L Tang","year":"2018","unstructured":"Tang L, Zheng Y, Melo MB, Mabardi L, Casta\u00f1o AP, Xie Y-Q, et al. Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery. Nat Biotechnol. 2018;36:707\u201316. https:\/\/doi.org\/10.1038\/nbt.4181.","journal-title":"Nat Biotechnol"},{"key":"8400_CR111","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1021\/jacs.2c08808","volume":"145","author":"TM Brown","year":"2023","unstructured":"Brown TM, Fakih HH, Saliba D, Asohan J, Sleiman HF. Stabilization of Functional DNA Structures with Mild Photochemical Methods. J Am Chem Soc. 2023;145:2142\u201351. https:\/\/doi.org\/10.1021\/jacs.2c08808.","journal-title":"J Am Chem Soc"},{"key":"8400_CR112","doi-asserted-by":"publisher","first-page":"6706","DOI":"10.1021\/acsnano.5b02796","volume":"9","author":"S Ramishetti","year":"2015","unstructured":"Ramishetti S, Kedmi R, Goldsmith M, Leonard F, Sprague AG, Godin B, et al. Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles. ACS Nano. 2015;9:6706\u201316. https:\/\/doi.org\/10.1021\/acsnano.5b02796.","journal-title":"ACS Nano"},{"key":"8400_CR113","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/nar\/30.8.1757","volume":"30","author":"T Holen","year":"2002","unstructured":"Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res. 2002;30:1757\u201366. https:\/\/doi.org\/10.1093\/nar\/30.8.1757.","journal-title":"Nucleic Acids Res"},{"key":"8400_CR114","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1038\/s41467-020-17952-5","volume":"11","author":"MA Coelho","year":"2020","unstructured":"Coelho MA, De Braekeleer E, Firth M, Bista M, Lukasiak S, Cuomo ME, et al. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs. Nat Commun. 2020;11:4132. https:\/\/doi.org\/10.1038\/s41467-020-17952-5.","journal-title":"Nat Commun"},{"key":"8400_CR115","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1182\/blood-2018-99-112996","volume":"132","author":"O Humbert","year":"2018","unstructured":"Humbert O, Radtke S, Carillo RR, Perez AM, Reddy SS, Schefter LE, et al. Persistence of CRISPR\/Cas9-Edited Hematopoietic Stem and Progenitor Cells and Reactivation of Fetal Hemoglobin in Nonhuman Primates. Blood. 2018;132:806. https:\/\/doi.org\/10.1182\/blood-2018-99-112996.","journal-title":"Blood"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08400-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08400-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08400-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:33:06Z","timestamp":1787884386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08400-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8400"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08400-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1107"}}